2026 NPPES data Plastic and Reconstructive Surgery Physician NPI 1780045682 MD
Verify on CMS →

MARK RIVERA, MD

Plastic and Reconstructive Surgery Physician in BEVERLY HILLS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 350 beneficiaries · Plastic and Reconstructive Surgery Physician avg: 86
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$28.96
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK RIVERA, MD is a Plastic and Reconstructive Surgery Physician ([object Object]) practicing in BEVERLY HILLS, California with a Medicare Part D prescribing footprint of 2K claims across 350 beneficiaries — 14% brand-name prescribing . Industry payments of $28.96 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK RIVERA, MD filed 1,825 Medicare Part D claims in 2023 across BEVERLY HILLS, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

MARK RIVERA, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

MARK RIVERA, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 03/19/2016

NPI 1780045682

Primary specialty

Plastic and Reconstructive Surgery Physician

Niche

2,352 US NPIs in this specialty

Medicare Part D claims

1,825 2022% vs specialty avg

2023 prescription claims

Specialty avg: 86

Specialty distribution in California

How Plastic and Reconstructive Surgery Physician compares to other specialties among California providers

California providers

Plastic and Reconstructive Surgery Physician share within California

1. Plastic and Reconstructive Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Plastic and Reconstructive Surgery Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Plastic and Reconstructive Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Plastic and Reconstructive Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Plastic and Reconstructive Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Plastic and Reconstructive Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK RIVERA, MD is a Plastic and Reconstructive Surgery Physician provider practicing in BEVERLY HILLS, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1780045682. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK RIVERA, MD appears in the CMS NPPES registry as a Plastic and Reconstructive Surgery Physician provider holding MD credentials at 9735 WILSHIRE BLVD, BEVERLY HILLS, CA, 90212, with a listed phone of (661) 251-6300. NPI 1780045682 was issued on 03/19/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RIVERA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,825 prescription claims written by this provider, covering 350 Medicare beneficiaries and totaling roughly $231K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 2.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 2,352 enrolled providers across 54 states and an average of 86 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9735 WILSHIRE BLVD
BEVERLY HILLS, CA 90212

Provider Details

NPI 1780045682
Specialty Plastic and Reconstructive Surgery Physician
Credentials MD
Gender Male
NPI Issued 03/19/2016

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK RIVERA, MD. Source: openpaymentsdata.cms.gov.

Total received

$29

Largest payer

ABIOMED

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARK RIVERA, MD. To verify MARK RIVERA, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARK RIVERA, MD — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 1,825 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,825
Total Claims
$231K
Total Drug Cost
350
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,616
Total Day Supply
99,884
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$203K
Generic Drug Cost
$27K
Opioid Claims
49 (2.7% rate)
Antibiotic Claims
174

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
1.37
Gender Split
60% female / 40% male
Age Distribution
<65: 32, 65-74: 183, 75-84: 109, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Albuterol Sulfate Hfa
Albuterol Sulfate
110
Lisinopril
79
Atorvastatin Calcium
78
Metformin Hcl
78
Azithromycin
62
Levothyroxine Sodium
51
Triamcinolone Acetonide
48
Amlodipine Besylate
43
Tamsulosin Hcl
42
Losartan Potassium
36

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Plastic and Reconstructive Surgery Physician Overview

How MARK RIVERA, MD fits within the Plastic and Reconstructive Surgery Physician landscape nationally.

2,352
Plastic and Reconstructive Surgery Physician Providers in US
54
States with Plastic and Reconstructive Surgery Physician
86
Avg Claims per Provider

MARK RIVERA, MD's 1,825 claims are above the specialty average of 86.

Nearby Plastic and Reconstructive Surgery Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as RIVERA.

Compare Plastic and Reconstructive Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK RIVERA, MD's specialty?
MARK RIVERA, MD specializes in Plastic and Reconstructive Surgery Physician and practices in BEVERLY HILLS, California. Credentials: MD.
How much does MARK RIVERA, MD prescribe under Medicare Part D?
In 2023, MARK RIVERA, MD wrote 1,825 Medicare Part D claims totaling $231K in drug costs for 350 beneficiaries.
Where is MARK RIVERA, MD located?
MARK RIVERA, MD is located at 9735 WILSHIRE BLVD, BEVERLY HILLS, CA, 90212. Phone: (661) 251-6300.
What is MARK RIVERA, MD's NPI number?
MARK RIVERA, MD's National Provider Identifier (NPI) is 1780045682, issued on 03/19/2016.
Does MARK RIVERA, MD prescribe more brand-name or generic drugs?
MARK RIVERA, MD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $203K in brand drug costs.
Does MARK RIVERA, MD prescribe opioids?
Yes, MARK RIVERA, MD had 49 opioid claims in 2023 with an opioid prescribing rate of 2.7%.
How many Plastic and Reconstructive Surgery Physician providers are there in the US?
There are 2,352 Plastic and Reconstructive Surgery Physician providers across 54 states in the US. The average Plastic and Reconstructive Surgery Physician provider writes 86 Medicare Part D claims per year.
What drugs does MARK RIVERA, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK RIVERA, MD's most frequently prescribed drugs include Albuterol Sulfate Hfa, Lisinopril, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK RIVERA, MD accept Medicare?
MARK RIVERA, MD appears in CMS Medicare data with 1,825 Part D claims and 350 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK RIVERA, MD's credentials?
MARK RIVERA, MD's NPI is 1780045682 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology